Cargando…

Supramaximal elevation in B-type natriuretic peptide and its N-terminal fragment levels in anephric patients with heart failure: a case series

INTRODUCTION: Little is known about the responses of natriuretic peptides to developing congestive heart failure in ‘anephric’ end-stage kidney disease. CASE PRESENTATION: We present three consecutive cases of surgically-induced anephric patients in a critical care environment: a 28-year-old Caucasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ting, John YC, Pussell, Bruce A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506524/ https://www.ncbi.nlm.nih.gov/pubmed/23062279 http://dx.doi.org/10.1186/1752-1947-6-351

Ejemplares similares

Anephric Neonate and Evolution of our Study on Intestinal Dialysis
por: Chatterjee, Uday Sankar
Publicado: (2021)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Marked elevations in N-terminal brain natriuretic peptide levels in septic shock
por: Chua, Gerald, et al.
Publicado: (2004)

Correlation between B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide in patients presenting to an emergency department with decompensated heart failure
por: Villacorta, H, et al.
Publicado: (2005)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Decreased albumin is associated with elevated N-terminal pro-brain natriuretic peptide and poor long-term prognosis in patients with chronic heart failure
por: Yi, Sheng, et al.
Publicado: (2020)

Correlation Between Levels of N-terminal Pro-B-Type Natriuretic Peptide and Degrees of Heart Failure
por: Song, Bong Geun, et al.
Publicado: (2005)

Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure
por: Bellagambi, Francesca G., et al.
Publicado: (2021)

N‐terminal pro‐B‐type natriuretic peptide and prognosis in Caucasian vs. Asian patients with heart failure
por: Tromp, Jasper, et al.
Publicado: (2018)

In-hospital brain natriuretic peptide and N-terminal prohormone brain natriuretic peptide variations are predictors of short-term and long-term outcome in acute decompensated heart failure
por: Di Somma, Salvatore, et al.
Publicado: (2011)

Cocoa flavanols reduce N‐terminal pro‐B‐type natriuretic peptide in patients with chronic heart failure
por: De Palma, Rodney, et al.
Publicado: (2015)

Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide
por: Zegard, Abbasin, et al.
Publicado: (2023)

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure
por: Ha Manh, Tuan, et al.
Publicado: (2023)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes
por: Hamano, Kumiko, et al.
Publicado: (2014)

Carbohydrate antigen 125 combined with N-terminal pro-B-type natriuretic peptide in the prediction of acute heart failure following ST-elevation myocardial infarction
por: Xu, Kaizu, et al.
Publicado: (2022)

The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors
por: Suzuki, Satoru, et al.
Publicado: (2018)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction
por: Tate, Samuel, et al.
Publicado: (2014)

Associates of an Elevated Natriuretic Peptide Level in Stable Heart Failure Patients: Implications for Targeted Management
por: Jan, Aftab, et al.
Publicado: (2013)

Effect of Valsartan on N-Terminal Pro-Brain Natriuretic Peptide in Patient With Stable Chronic Heart Failure: Comparison With Enalapril
por: Lee, Young Soo, et al.
Publicado: (2011)

Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure
por: Chang, Huai-Ren, et al.
Publicado: (2013)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Urine N‐terminal pro b‐type natriuretic peptide is predictive of heart failure‐related emergency department visits
por: Chen, Ju‐Yi, et al.
Publicado: (2020)

The minimal informative monitoring interval of N-terminal pro-B-type natriuretic peptide in patients with stable heart failure
por: Dai, Zhehao, et al.
Publicado: (2020)

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction
por: Januzzi, James L., et al.
Publicado: (2021)

N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator
por: Deng, Yu, et al.
Publicado: (2022)

Combined Use of Serum N-terminal Pro-B-Type Natriuretic Peptide and Glypican-6 in the Diagnosis of Heart Failure
por: Sağlam, Emre Cem, et al.
Publicado: (2023)

Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide
por: Nordling, Pauliina, et al.
Publicado: (2016)

N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes [Corrigendum]
Publicado: (2014)

Generation of pluripotent stem cell-derived mouse kidneys in Sall1-targeted anephric rats
por: Goto, Teppei, et al.
Publicado: (2019)

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function
por: Jafri, Lena, et al.
Publicado: (2013)

Diastolic but not systolic dysfunction is associated with troponin and N-terminal pro-brain natriuretic peptide elevation in sepsis
por: Landesberg, G, et al.
Publicado: (2009)

Hospitalization and medical cost of patients with elevated serum N-terminal pro-brain natriuretic peptide levels
por: Kitagawa, Toshiro, et al.
Publicado: (2018)

Relationship between N-Terminal Pro-Brain Natriuretic Peptide, Obesity and the Risk of Heart Failure in Middle-Aged German Adults
por: Wirth, Janine, et al.
Publicado: (2014)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients With Acute Heart Failure
por: Wang, Kai, et al.
Publicado: (2020)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9hsouvrcc5s1b8riase0bfmllb